Product Information

APREPITANT 40 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $41.3767 per EA under NDC 68462058340. Its NADAC has been published 440 times since Jun 20, 2018.

FDA first approved this application on Oct 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

APREPITANT 40 MG CAPSULE

Aprepitant
$41.3767per EA

Strength

40 mg/1

NDC

68462058340

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

APREPITANT

Approval Type

Generic (ANDA)

FDA Application

ANDA207777

FDA Approved

10/12/2017

TE Code

AB

On Market Since

10/12/2017

Pharmacological Classes

Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist

Price Statistics

The NADAC for APREPITANT 40 MG CAPSULE has been published 440 times since Jun 20, 2018, and over the history we have for it it has declined 45.5%. The table below summarizes its recorded NADAC range and movement.

Current price$41.3767 per EA
All-time high$83.7756 (Aug 12, 2020)
All-time low$34.4783 (Nov 20, 2024)
52-week high$47.4921
52-week low$38.1856
Median price$63.9920
Average price$62.6516
Largest weekly change+42.7% (Feb 22, 2023)
Weeks tracked440
Tracking sinceJun 20, 2018

Price History

1W

-8.3%

1M

-10.9%

3M

-8.8%

6M

+8.4%

1Y

-8.2%

3Y

-31.3%

5Y

-34.2%

All

-45.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of APREPITANT 40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 40 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $41.3767 per EA (NDC 68462058340), effective Nov 18, 2026.

How has the price of APREPITANT 40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for APREPITANT 40 MG CAPSULE has declined 45.5%. It has been tracked across 440 weekly CMS publications since Jun 20, 2018.

What are the highest and lowest recorded NADAC prices for APREPITANT 40 MG CAPSULE?

Since Jun 20, 2018, the NADAC for APREPITANT 40 MG CAPSULE has ranged from a low of $34.4783 (Nov 20, 2024) to a high of $83.7756 (Aug 12, 2020), with a median of $63.9920 per EA.

Are there cheaper alternatives to APREPITANT 40 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as APREPITANT 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures APREPITANT 40 MG CAPSULE?

APREPITANT 40 MG CAPSULE (NDC 68462058340) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.